Biosimilars: A revolution for biologics in the pharmaceutical industry
This project report is submitted in partial fulfilment of the requirements for the degree of Bachelor of Pharmacy, 2017.
Hoofdauteur: | Moreino, Shannon Sherwin |
---|---|
Andere auteurs: | Kabir, Eva Rahman |
Formaat: | Project report |
Taal: | English |
Gepubliceerd in: |
BRAC University
2018
|
Onderwerpen: | |
Online toegang: | http://hdl.handle.net/10361/9331 |
Gelijkaardige items
-
Biologics and Biosimilars as Treatment Options for Psoriasis
door: Moya, Amena Khatun
Gepubliceerd in: (2023) -
Biosimilar in lymphoma treatment
door: Tanisha, Mehrin Haque
Gepubliceerd in: (2021) -
Biosimilar insulins: a potential option in the treatment of Diabetes
door: Tabassum, Turana
Gepubliceerd in: (2022) -
Concepts and challenges of biosimilars to mitigate the oncology drug expenses
door: Tania, Umme
Gepubliceerd in: (2021) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
door: Tania, Umme
Gepubliceerd in: (2023)